miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

por White, N M A, Khella, H W Z, Grigull, J, Adzovic, S, Youssef, Y M, Honey, R J, Stewart, R, Pace, K T, Bjarnason, G A, Jewett, M A S, Evans, A J, Gabril, M, Yousef, G M
Publicado 2011

Childhood leukaemia and socioeconomic status in England and Wales 1976–2005: evidence of higher incidence in relatively affluent communities persists over time

por Kroll, M E, Stiller, C A, Murphy, M F G, Carpenter, L M
Publicado 2011

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1

por Bertrand, Y, Currie, J-C, Poirier, J, Demeule, M, Abulrob, A, Fatehi, D, Stanimirovic, D, Sartelet, H, Castaigne, J-P, Béliveau, R
Publicado 2011

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer

por Thomas, F, Motsinger-Reif, A A, Hoskins, J M, Dvorak, A, Roy, S, Alyasiri, A, Myerson, R J, Fleshman, J W, Tan, B R, McLeod, H L
Publicado 2011

Risk of renal cell carcinoma in relation to blood telomere length in a population-based case–control study

por Hofmann, J N, Baccarelli, A, Schwartz, K, Davis, F G, Ruterbusch, J J, Hoxha, M, McCarthy, B J, Savage, S A, Wacholder, S, Rothman, N, Graubard, B I, Colt, J S, Chow, W-H, Purdue, M P
Publicado 2011

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

por Bose, D, Zimmerman, L J, Pierobon, M, Petricoin, E, Tozzi, F, Parikh, A, Fan, F, Dallas, N, Xia, L, Gaur, P, Samuel, S, Liebler, D C, Ellis, L M
Publicado 2011

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome

por Journe, F, Boufker, H Id, Van Kempen, L, Galibert, M-D, Wiedig, M, Salès, F, Theunis, A, Nonclercq, D, Frau, A, Laurent, G, Awada, A, Ghanem, G
Publicado 2011

Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

por Morimura, R, Komatsu, S, Ichikawa, D, Takeshita, H, Tsujiura, M, Nagata, H, Konishi, H, Shiozaki, A, Ikoma, H, Okamoto, K, Ochiai, T, Taniguchi, H, Otsuji, E
Publicado 2011

MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer

por Myklebust, M P, Bruland, O, Fluge, Ø, Skarstein, A, Balteskard, L, Dahl, O
Publicado 2011

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT

por Bryant, J L, Britson, J, Balko, J M, Willian, M, Timmons, R, Frolov, A, Black, E P
Publicado 2012

Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis

por Hur, H, Kim, N K, Kim, H G, Min, B S, Lee, K Y, Shin, S J, Cheon, J H, Choi, S H
Publicado 2012

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma

por Erlich, R B, Kherrouche, Z, Rickwood, D, Endo-Munoz, L, Cameron, S, Dahler, A, Hazar-Rethinam, M, de Long, L M, Wooley, K, Guminski, A, Saunders, N A
Publicado 2012

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

por McMeekin, S, Patel, R, Verschraegen, C, Celano, P, Burke, J, Plaxe, S, Ghatage, P, Giurescu, M, Stredder, C, Wang, Y, Schmelter, T
Publicado 2012

Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families

por Chang, C M, Yu, K J, Hsu, W L, Major, J M, Chen, J Y, Lou, P J, Liu, M Y, Diehl, S R, Goldstein, A M, Chen, C J, Hildesheim, A
Publicado 2012

Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network Do the results of international clinical trials translate...

por Webster, R M, Abraham, J, Palaniappan, N, Caley, A, Jasani, B, Barrett-Lee, P
Publicado 2012

Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma

por Kurashige, J, Watanabe, M, Iwatsuki, M, Kinoshita, K, Saito, S, Hiyoshi, Y, Kamohara, H, Baba, Y, Mimori, K, Baba, H
Publicado 2012

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study

por Bradley, M C, Murray, L J, Cantwell, M M, Hughes, C M
Publicado 2012

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women

por Kabat, G C, Kim, M Y, Strickler, H D, Shikany, J M, Lane, D, Luo, J, Ning, Y, Gunter, M J, Rohan, T E
Publicado 2012

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer

por Ferdinande, L, Decaestecker, C, Verset, L, Mathieu, A, Moles Lopez, X, Negulescu, A-M, Van Maerken, T, Salmon, I, Cuvelier, C A, Demetter, P
Publicado 2012

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma

por Algazi, A P, Weber, J S, Andrews, S C, Urbas, P, Munster, P N, DeConti, R C, Hwang, J, Sondak, V K, Messina, J L, McCalmont, T, Daud, A I
Publicado 2012